Abstract:Abstract The low activity and yield of antimicrobial peptides (AMPs) are pressing problems. The improvement of activity and yield through modification and heterologous expression, a potential way to solve the problem, is a research hot-pot. In this work, a new plectasin-derived variant L-type AP138 (AP138L-arg26) was constructed for the study of recombination expression and druggablity. As a result, the total protein concentration of AP138L-arg26 was 3.1 mg/mL in Pichia pastoris X-33 supernatant after 5 days of induction expression in a 5-L fermenter. The recombinant peptide AP138L-arg26 has potential antibacterial activity against selected standard and clinical Gram-positive bacteria (G + , minimum inhibitory concentration (MIC) 2–16 μg/mL) and high stability under different conditions (temperature, pH, ion concentration) and 2 × MIC of AP138L-arg26 could rapidly kill Staphylococcus aureus ( S. aureus ) (> 99.99%) within 1.5 h. It showed a high safety in vivo and in vivo and a long post-antibiotic effect (PAE, 1.91 h) compared with vancomycin (1.2 h). Furthermore, the bactericidal mechanism was revealed from two dimensions related to its disruption of the cell membrane resulting in intracellular potassium leakage (2.5-fold higher than control), and an increase in intracellular adenosine triphosphate (ATP), and reactive oxygen species (ROS), the decrease of lactate dehydrogenase (LDH) and further intervening metabolism in S. aureus . These results indicate that AP138L-arg26 as a new peptide candidate could be used for more in-depth development in the future. Key points • The AP138L-arg26 was expressed in the P. pastoris expression system with high yield • The AP138 L-arg26 showed high stability and safety in vitro and in vivo • The AP138L-arg26 killed S. aureus by affecting cell membranes and metabolism

[Secreted Expression of the Combinant Antimicrobial Peptide PL in Pichia Pastoris and Its Antibacterial Activity in Vitro].

Recombinant Expression of Antimicrobial Peptides in Pichia Pastoris: A Strategy to Inhibit the Penicillium Expansum in Pears

The Molecular Design of a Recombinant Antimicrobial Peptide CP and Its in Vitro Activity

[Synthesis of Hybrid Antimicrobial Peptide CecA-mag Gene and It's Secretion Expression in Pichia Pastoris].

Secreted Expression and Activity Detection of Two Hybrid Antimicrobial Peptides in Pichia Pastoris

In vitro and in vivo activity of the dimer of PMAP-36 expressed in Pichia pastoris.

Modification of Hybrid Antimicrobial Peptide CecA-mil Gene and Its Over-Secretion Expression in Pichia Pastoris

Study on recombinant expression of antimicrobial peptides FAPs in Pichia pastoris

Secretive Expression of Insect Antifungal Peptide-Encoded Genes in Pichia Pastoris and Activity Assay of the Products

Expression and characterization of the new antimicrobial peptide AP138L-arg26 anti Staphylococcus aureus

Expression and Characterization of Recombinant Porcine Β-Defensin-2 Gene in Pichia Pastoris

Antibacterial peptide PMAP-37(F34-R), expressed in Pichia pastoris, is effective against pathogenic bacteria and preserves plums

Expression and characterization of antimicrobial peptide ABP-CM4 in methylotrophic yeast Pichia pastoris

Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG

A Eukaryotic Expression Strategy for Producing the Novel Antimicrobial Peptide PRW4

High Expression of the Human Antibacterial Peptide LL-37 in Pichia pastoris and the Detection of Its Activity

Codon Optimization of Antibacterial Peptide Magainin and CecA-mil Gene and Over -expression in Pichia pastoris

Expression of Plectasin in Pichia Pastoris and Its Characterization As a New Antimicrobial Peptide Against Staphyloccocus and Streptococcus.

Expression and Characterization of the Antimicrobial Peptide ABP-dHC-cecropin A in the Methylotrophic Yeast Pichia Pastoris.

Expression and Activity Analysis of Antimicrobial Peptide Defensin in Pichia pastoris Yeast

Expression of Hybrid Peptide EF-1 in Pichia pastoris, Its Purification, and Antimicrobial Characterization